Pipeline

A Pipeline focused on high unmet medical needs

pipeline january 2026

ST-01 and ST-02 Phase II studies underway

  • Successfully completed Phase I trial results of this study were recently published
  • Phase II trials of ST-01 are underway in Post-Operative Pain and Chronic Scrotal Pain
  • Phase II trials planned for Chronic Pelvic Pain
  • Phase II trial of ST-02 underway for Upper Tract Urothelial Cancer

Product/Clinical Development Focus

  • Rich pipeline based on platform technology
  • Sustained-release lidocaine (ST-01):
    Chronic Pain; Post-Operative Pain
  • Sustained-release gemcitabine (ST-02):
    Upper Tract Urothelial Carcinoma
  • Sustained release alprostadil (ST-04) under development for erectile dysfunction